Rhabdomyolysis and renal function impairment after isolated limb perfusion—Comparison between the effects of perfusion with rhTNFα and a ‘triple-drug’ regimen

References

1. • Thompson JF
   • Gianoutsos MP
   Isolated limb perfusion for melanoma: effectiveness and toxicity of cisplatin compared with that of melphalan and other drugs.
   World J Surg. 1992; 16: 227-233
   • Google Scholar
2. • Wieberdink J
   • Bockhuizen C
   • Braat RP
   • van Slooten EA
   • Otthuis GAA
   Dosimetry in isolation perfusion of the limbs by assessment of perfused tissue volume and grading of toxic tissue reactions.
   Eur J Cancer Clin Oncol. 1982; 18: 905-910
   • Google Scholar
3. • Lienard D
   • Ewalenko P
   • Delmotte JJ
   • Renard N
   • Lejeune FJ
   High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma.
   J Clin Oncol. 1992; 10: 52-60
   • Google Scholar
4. • Vaglini M
   • Belli F
   • Ammatuna M
   • et al.
   Treatment of primary or relapsing limb cancer by isolation perfusion with high-dose TNF alpha, gamma-interferon, and melphalan.
   Cancer. 1994; 73: 483-492
   • Google Scholar
5. • Eggimann P
   • Chiolero R
   • Chassot PG
   • Lienard D
   • Gerain J
   • Lejeune F
   Systemic and hemodyriamic effects of recombinant tumor necrosis factor alpha in isolation perfusion of the limbs.
   Chest. 1995; 107: 1074-1082
   • Google Scholar
6. • Fletcher WS
   • Pommier RF
   • Woltering EA
   • Mueller CR
   • Ash KO
   • Small KA
   Pharmacokinetics and results of dose escalation in cis-platin hyperthermic isolation limb perfusion.
   Ann Surg Oncol. 1994; 1: 236-243
   • Google Scholar
7. • Rauschecker HF
   • Osterloh B
   Acute renal failure following hyperthermic isolation perfusion of the left leg.
   Anticancer Res. 1987; 7: 451-454
   • Google Scholar
8. • Lienard D
   • Eggermont AM
   • Schaffordt Koops H
   • et al.
   Isolated perfusíon of the limb with high-dose tumour necrosis factor-alpha (TNF-alpha), interferon-gamma (IFN-gamma) and melphalan for melanoma stage III. Results of a multicentre pilot study.
   Melanoma Res. 1994; 4: 21-26
   • Google Scholar
9. • Vaglini M
   • Santinami M
   • Manzi R
   • et al.
   Treatment of in-transit métastases from cutaneous melanoma by isolation perfusion with tumor necrosis factor-alpha (TNFα), melphalan, and interferon-gamma (IFN-g). Dose-finding experience at the National Cancer Institute of Milan.
   Melanoma Res. 1994; 8: 35
   • Google Scholar
10. • Eggermont AM
    • Schraffordt Koops H
    • Lienard D
    • et al.
    Isolated limb perfusion with high dose tumor necrosis factor alpha in combination with interferon gamma and melphalan for irresectable extremity soft tissue sarcomas: a multicenter trial.
    J Clin Oncol. 1996; 14: 2653-2665
    • Google Scholar
11. • Schlag P
    • Kettelhack C
    Weichteilsarkome: die hypertherme Extremitätenperfusion—Technik und Indikationen.
    Chirurg. 1993; 64: 455-460
    • Google Scholar
12. • Sprenger HJ
    • Markwardt J
    • Schlag P
    Quantitative Leckkontrolle mit Radionukliden bei der isolierten Extremitätenperfusion.
    Nucl Med. 1994; 33: 248-253
    • Google Scholar
13. • Krementz ET
    • Muchmore JH
    • Carter RD
    • Sutherland CM
    Multiple perfusions for melanoma.
    Melanoma Res. 1994; 4: 39-44
    • Google Scholar
14. • Lejeune FJ
    • Lienard D
    • el Douaihy M
    • Seyedi JV
    • Ewalenko P
    Results of 206 isolated limb perfusions for malignant melanoma.
    Eur J Surg Oncol. 1989; 15: 510-519
    • Google Scholar
15. • Thompson JF
    • Lai DT
    • Ingvar C
    • Kam PC
    Maximizing efficacy and minimizing toxicity in isolated limb perfusion for melanoma.
    Melanoma Res. 1994; 4: 45-50
    • Google Scholar
16. • Odeh M
    A possible role for antibodies to tumour necrosis factor alpha and to endotoxin in the treatment of Reye's syndrome.
    Gut. 1995; 37: 441-443
    • Google Scholar
17. • Pan M
    • Wasa M
    • Lind DS
    • Gertler J
    • Abbott W
    • Souba WW
    TNF-stimulated arginine transport by human vascular endothelium requires activation of protein kinase C.
    Ann Surg. 1995; 221: 590-600
    • Google Scholar
18. • Panteghini M
    • Cuccia C
    • Malchiodi A
    • Calarco M
    • Pagnoni N
    Isoforms of creatine kinase MM and MB in acute myocardial infarction: a clinical evaluation.
    Clin Chim Acta. 1986; 155: 1-9
    • Google Scholar
19. • Edwards MJ
    • Miller FN
    • Sims DE
    • Abney DL
    • Schuschke DA
    • Corey TS
    Interleukin 2 acutely induces platelet and neutrophil-endothelial adherence and macromolecular leakage.
    Cancer Res. 1992; 52: 3425-3431
    • Google Scholar
20. • Köppel C
    Clinical features, pathogenesis, and management of drug-induced rhabdomyolysis.
    Med Toxicol Adv Drug Exp. 1989; 4: 108-126
    • Google Scholar
21. • Klemm A
    • Zwettler U
    • Ritz E
    • Stein G
    Akutes myoglobinurisches Nierenversagen.
    Intensivmed. 1994; 31: 436-441
    • Google Scholar
22. • Hill S
    • Fawcett WJ
    • Sheldon J
    • Soni N
    • Williams T
    • Thomas JM
    Low-dose tumour necrosis factor alpha and melphalan in hyperthermic isolated limb perfusion.
    Br J Surg. 1993; 80: 995-997
    • Google Scholar
23. • Kallinowski F
    • Schaefer C
    • Tyler G
    • Vaupel P
    In vivo targets of recombinant human tumour necrosis factor-alpha: blood flow, oxygen consumption and growth of isotransplanted rat tumours.
    Br J Cancer. 1989; 60: 555-560
    • Google Scholar
24. • McCord J
    Oxygen-derived free radicals in postischemic tissue injury.
    N Engl J Med. 1985; 312: 159-163
    • Google Scholar
25. • Odeh M
    The role of reperfusion-induced injury in the pathogenesis of the crush syndrome.
    N Engl J Med. 1991; 324: 1417-1422
    • Google Scholar
26. • Better OS
    • Stein JH
    Early management of shock and prophylaxis of acute renal failure in traumatic rhabdomyolysis.
    N Engl J Med. 1990; 322: 825-829
    • Google Scholar
27. • Adiseshiah M
    • Round JM
    • Jones DA
    Reperfusion injury in skeletal muscle: a prospective study in patients with limb ischaemia and claudicants treated by revascularization.
    Br J Surg. 1992; 79: 1026-1029
    • Google Scholar
28. • Ron D
    • Taitelman U
    • Michaelson M
    • Bar-Joseph G
    • Bursztein S
    • Better OS
    Prevention of acute renal failure in traumatic rhabdomyolysis.
    Arch Int Med. 1984; 144: 277-280
    • Google Scholar
29. • Baldwin L
    • Henderson A
    • Hickman P
    Effect on postoperative low-dose dopamine on renal function after elective major vascular surgery.
    Ann Intern Med. 1994; 120: 744-747
    • Google Scholar
30. • Sternbergh WC
    • Makhoul RG
    • Adelman B
    • Odeh M
    Nitric oxide-mediated, endothelium-dependent vasodilation is selectively attenuated in the postischemic extremity. A possible role for antibodies to tumour necrosis factor alpha and to endotoxin in the treatment of Reye's syndrome.
    Surgery. 1995; 37: 441-443
    • Google Scholar
31. • Walker PM
    • Lindsay TF
    • Labbe R
    • Mickle DA
    • Romaschin AD
    Salvage of skeletal muscle with free radical scavengers.
    J Vasc Surg. 1987; 5: 68-75
    • Google Scholar